RGLS Regulus Therapeutics, Inc. Operatsion rentabellik

RGLS (Regulus Therapeutics, Inc.) - kompaniyaning tovar belgisi

Buyrak patologiyalari uchun RNK terapiyalarini ishlab chiqishdagi muvaffaqiyatlar GURU.Markets grafigidagi operatsion foyda marjalarini belgilaydi, u yerda 0.00 yangi darajani qayd etmoqda. Jay Haganning samarali rahbarligi ilmiy tadqiqotlar uchun kapital oqimlarini ta'minladi. Shu bilan birga, operatsion jarayonlar Regulus Therapeutics (RGLS) uchun biomateriallarni utilizatsiya qilishga oid FDA tibbiy qoidalari bilan qat'iy cheklangan.

RGLS: Regulus Therapeutics, Inc. Sotuvning operatsion rentabelligi 04.07.2022 - 05.07.2025

Regulus Therapeutics (RGLS) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning dastlabki tahlili:Regulus, RGLS
Regulus brendining mahsuloti

Operatsion marja Regulus Therapeutics (RGLS) asosiy faoliyatining samaradorligini aks ettiradi va qarz hamda soliq majburiyatlari hisobga olinishidan oldin jami daromadning operatsion foyda ulushini ifodalaydi. Ushbu operatsion marjani tahlil qilish fabless modeli va ishlab chiqarishni CMO larga autsorsing qilish xarajatlarni qanday optimallashtirishini baholash imkonini beradi, bu esa RNA dori vositalarini ishlab chiqish davrida biznesning fundamental barqarorligini belgilaydi.

Raqobatdosh kompaniyalar tahlili

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Maze Therapeutics, Inc. - Operatsion marja|Operatsion faoliyat rentabelligi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operatsion rentabellik|TSHA: Operatsion foyda koeffitsiyenti|Operatsion rentabellik uniQure Pharma|MGTX - Operatsion foyda bo'yicha marjinallik|Operatsion marja RGNX|Operatsion rentabellik SLDB (Solid Biosciences)|Ocugen Corp - Sotuvning operatsion marjasi|PACB: Operatsion foyda bo'yicha sotuv rentabelligi|benitec.com - Operatsion marja|DSGN - Operatsion marja|RCKT: Operatsion marja|FDMT (4D Molecular Therapeutics Inc) - Operatsion rentabellik|Sotuvning operatsion marjasi LXEO|Operatsion rentabellik KRRO|Operatsion marja EDIT|SLN - Sotuvning operatsion rentabelligi|Operatsion marja PRQR (ProQR)|CDXS - Sotuvning operatsion marjasi|Sangamo Therapeutics Inc. - Operatsion marja|NAUT - Operatsion marja|MGX: Operatsion marja|Sotuvning operatsion marjasi Precision BioSciences, Inc.|GBIO (Generation Bio) - Operatsion marja|Boundless Bio Inc. (BOLD) - Operatsion faoliyat rentabelligi|Sotuvning operatsion marjasi XCUR (exicuretx.com)|Imunon Inc - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja PHIO (Phio Pharmaceuticals Corp)|Operatsion foyda normasi MBIO|RNAZ - Operatsion rentabellik|Operatsion foyda normasi BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Operatsion rentabellik|Bluebird Bio - Operatsion foyda normasi|IPA (ImmunoPrecise Antibodies Ltd) - Operatsion marja|Sotuvning operatsion rentabelligi Omega Therapeutics, Inc. OMGA|Operatsion marja OMIC|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik